Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page
- Check3 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2, indicating a new version of the page has been released. This reflects a deployment update rather than a substantive change to study content or functionality.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecruitment status is updated to indicate no longer looking for participants, and new guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added; the Intervention/Treatment header has been reformatted for consistency.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page revision was bumped from v3.5.4 to v3.5.5 as a minor maintenance update. This does not alter the study details or other user-facing content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4. This update does not modify study details or data presented on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedA location spelling is corrected so the Parramatta, New South Wales site name is consistent. The page’s revision/version label is updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.